Second booster for over 50 & monkeypox antivirals with Andrea Garcia, JD, MPH | COVID-19 Update

• CDC Emergency Operations Center contact phone number (monkeypox): 770-488-7100
• Information for Healthcare Providers on Obtaining and Using TPOXX (Tecovirimat) for Treatment of Monkeypox: https://www.cdc.gov/poxvirus/monkeypox/clinicians/obtaining-tecovirimat.html

AMA Director of Science, Medicine and Public Health Andrea Garcia on the latest from the FDA and CDC, covering Novavax vaccine updates, getting a second booster shot, and continued spread of monkeypox across the United States. American Medical Association CXO Todd Unger hosts.

0:00 AMA COVID-19 Update for July 20, 2022
0:28 BA.5 is most transmissible and has emerged as the country’s dominant variant
1:49 COVID hospitalizations are up 20% since the beginning of July
2:56 FDA has authorized the Novavax vaccine for adults 18 and older as primary series only
4:23 What data is the FDA’s authorization based on?
5:51 New CDC report confirms first and second mRNA booster shots helped bolster people’s levels of protection against Omicron subvariants—and restored some protection that was lost since last shot
6:56 Administration officials are developing a plan for all adults to receive a second booster shot, contingent on FDA and CDC sign-off
7:52 COVID-19 Public Health Emergency declaration has been extended through October 13
8:44 What about progress on vaccinating kids under 5 years old?
10:09 Monkeypox outbreak is growing in the United States
11:17 Are monkeypox antivirals easily accessible?

Stay up to date on the latest information about the pandemic: https://ama-assn.org/covid-19-resources.
Visit the COVID-19 Daily Video Updates page for more videos in this series: https://ama-assn.org/covid-19-videos.